Skip to main content
. 2017 May 19;60(8):1390–1399. doi: 10.1007/s00125-017-4289-0

Fig. 1.

Fig. 1

Trial design. Thick black arrows, study medication dose; thin black arrows, dose escalation; orange arrows, PK sampling; PD assessment comprised: IVGTT, AST, 24 h profiles and GGIT. T2D, type 2 diabetes